Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plasma Administration”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT05971056
What this trial is testing

Providing Cancer Care Closer to Home for Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Washington University School of Medicine 3
Testing effectiveness (Phase 2)UnknownNCT03767751
What this trial is testing

A Feasibility and Safety Study of Dual Specificity CD38 and BCMA CAR-T Cell Immunotherapy for Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Chinese PLA General Hospital 80
Early research (Phase 1)Study completedNCT00058227
What this trial is testing

Alvocidib, Fludarabine Phosphate, and Rituximab in Treating Patients With Lymphoproliferative Disorders or Mantle Cell Lymphoma

Who this might be right for
B-cell Chronic Lymphocytic LeukemiaContiguous Stage II Grade 1 Follicular LymphomaContiguous Stage II Grade 2 Follicular Lymphoma+40 more
National Cancer Institute (NCI) 37
Testing effectiveness (Phase 2)Looking for participantsNCT06505369
What this trial is testing

Bispecific T-cell Redirectors as Part of First Line Treatment in Transplant Eligible Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
North Estonia Medical Centre 50
Not applicableUnknownNCT03504631
What this trial is testing

Genotyping and Phenotyping of CYP2D6 Breast Cancer Patients on Tamoxifen

Who this might be right for
Breast Cancer Female
Trisakti University 117
Testing effectiveness (Phase 2)Study completedNCT01790737
What this trial is testing

First Line Treatment Trial in Multiple Myeloma, Finnish Myeloma Group- Multiple Myeloma 02

Who this might be right for
Multiple Myeloma
Kuopio University Hospital 80
Testing effectiveness (Phase 2)Study completedNCT00036023
What this trial is testing

Chemotherapy Related Anemia in Patients With Non-Myeloid Malignancies

Who this might be right for
LymphomaBreast NeoplasmsLung Neoplasms+2 more
Amgen
Not applicableStudy completedNCT06161727
What this trial is testing

Detection and Prevalence of Human Papillomavirus (HPV) in Seminal Plasma and/or on Sperm in Men Undergoing Treatment With IVF/ICSI.

Who this might be right for
Human Papilloma VirusInfertility, Male
Vastra Gotaland Region 260
Not applicableUnknownNCT00258869
What this trial is testing

Observational Study of Sepsis and Pneumonia to Develop Diagnostic Tests

Who this might be right for
SepsisSepticemiaSepsis Syndrome+2 more
National Center for Genome Resources 1,200
Testing effectiveness (Phase 2)UnknownNCT05066646
What this trial is testing

A Fully Human BCMA-targeting CAR (CT103A) in Patients With Relapsed/Refractory Multiple Myeloma (FUMANBA-1)

Who this might be right for
Multiple Myeloma
Nanjing IASO Biotechnology Co., Ltd. 132
Not applicableUnknownNCT03078686
What this trial is testing

Biocellular-Cellular Regenerative Treatment Scaring Alopecia and Alopecia Areata

Who this might be right for
Alopecia AreataScarring Alopecia
Regeneris Medical 60
Large-scale testing (Phase 3)Study completedNCT00587405
What this trial is testing

Cyrotherapy vs. APC in GAVE

Who this might be right for
Watermelon Stomach
Mayo Clinic 60
Large-scale testing (Phase 3)Study completedNCT04816942
What this trial is testing

Clinical Efficacy of Early Administration of Convalescent Plasma Among COVID-19 Cases in Egypt

Who this might be right for
Convalescent PlasmaCovid19Immunoglobulins+2 more
Ministry of Health and Population, Egypt 102
Testing effectiveness (Phase 2)Study completedNCT01029054
What this trial is testing

Carfilzomib and Lenalidomide With Dexamethasone Combination in Newly Diagnosed, Previously Untreated Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Michigan Rogel Cancer Center 53
Not applicableNot Yet RecruitingNCT07838805
What this trial is testing

Changing in Plasma Concentration of a New Form of Creatine

Who this might be right for
Creatine
University of Padova 9
Not applicableStudy completedNCT03601494
What this trial is testing

Perineural Platelet-rich Plasma for Diabetic Neuropathy Pain

Who this might be right for
Diabetic NeuropathiesChronic Pain
Assiut University 60
Early research (Phase 1)WithdrawnNCT02561520
What this trial is testing

Safety and Efficacy of Autologous PRP and PPP Eye Drops in the Treatment of Ocular GVHD

Who this might be right for
Graft-versus-host Disease
Ladan Espandar
Not applicableStudy completedNCT06404424
What this trial is testing

Combined Hemoperfusion and Therapeutic Plasma Exchange for Treatment of Patients With Septic Shock

Who this might be right for
SepsisSeptic Shock
Efferon JSC 82
Large-scale testing (Phase 3)Study completedNCT04093583
What this trial is testing

Randomized Clinical Trial, Conventional Treatment-controlled, Studying the Efficacy of Plasma Rich in Growth Factor (PRGF®) in Alveolar Ridge Preservation After Simple Exodontia in the Anterior Region of Maxilla.

Who this might be right for
Dental Implantation
Fundación Eduardo Anitua 46
Not applicableUnknownNCT02797041
What this trial is testing

Bortezomib as First Salvage Therapy for Myeloma Patients Previously Exposed to Bortezomib as Initial Treatment.

Who this might be right for
Multiple Myeloma
IRCCS Centro di Riferimento Oncologico della Basilicata 100
Next Page